Jaguar Health (NASDAQ:JAGX) Sees Large Volume Increase
Shares of Jaguar Health Inc (NASDAQ:JAGX) saw an uptick in trading volume on Wednesday . 1,591,549 shares traded hands during trading, an increase of 613% from the previous session’s volume of 223,146 shares.The stock last traded at $2.79 and had previously closed at $2.70.
Several analysts have recently issued reports on JAGX shares. ValuEngine lowered shares of Zumiez from a “hold” rating to a “sell” rating in a research note on Tuesday, July 2nd. HC Wainwright set a $10.00 target price on shares of Jaguar Health and gave the stock a “buy” rating in a research note on Tuesday, July 2nd. Finally, Zacks Investment Research upgraded shares of Booz Allen Hamilton from a “hold” rating to a “buy” rating and set a $71.00 target price for the company in a research note on Friday, June 28th.
The company has a current ratio of 0.30, a quick ratio of 0.18 and a debt-to-equity ratio of 0.02. The stock has a market cap of $4.04 million, a PE ratio of -0.02 and a beta of 0.70. The company has a 50 day simple moving average of $4.13.
Jaguar Health Company Profile (NASDAQ:JAGX)
Jaguar Health, Inc, a commercial stage natural-products pharmaceuticals company, focuses on developing gastrointestinal products for human prescription use and animals worldwide. The company, through its wholly-owned subsidiary, Napo Pharmaceuticals, Inc, focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas.
Recommended Story: Futures Contract
Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with MarketBeat.com's FREE daily email newsletter.